Intellia Therapeutics (NTLA) P/E (2016 - 2026)
Intellia Therapeutics (NTLA) P/E from Jun 30, 2016 to Jul 20, 2026. The TTM Intellia Therapeutics (NTLA) P/E is -3.16. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Intellia Therapeutics (NTLA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.16 | +32.19% |
| 2025 | -2.39 | +6.66% |
| 2024 | -2.24 | -61.48% |
| 2023 | -5.81 | -2.75% |
| 2022 | -5.98 | -81.08% |
| 2021 | -31.60 | +33.06% |
| 2020 | -23.75 | +1442.89% |
| 2019 | -1.54 | -77.95% |
| 2018 | -6.98 | -45.45% |
| 2017 | -12.80 | -61.00% |
| 2016 | -32.82 | N/A |
Comparison Intellia Therapeutics (NTLA) P/E with competitors
Intellia Therapeutics (NTLA) P/E is -3.16.